Onyx Pharmaceuticals, Inc. (ONXX) Misses Q1 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures slide as rising oil, yields dampen mood
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Join SI Premium – FREE
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q1 EPS of ($0.68), $0.13 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $72 million versus the consensus estimate of $69.82 million.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
- Swvl reports 59% revenue rise to $16.2M in H1 2026
- Old Dominion Freight Line (ODFL) PT Lowered to $230 at Stifel Amid Stabilising Freight Demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
